In March, 1999, House Bill 2117 was signed by Governor Bill Graves. Therapeutic licensees can prescribe oral antibacterial drugs, oral antiviral drugs, oral antihistamines and oral analgesic drugs for ocular conditions. Oral steroids and oral antiglaucoma agents for ocular conditions must be prescribed in consultation with an ophthalmologist.
Any license number lower than 1132 was originally issued as a No Pharmaceutical Agents (NPA) license and must have a -1 suffix for Diagnostic Pharmaceutical Agent (DPA) privileges, a -2 suffix for Therapeutic Pharmaceutical (TPA) privileges, or a -3 for Glaucoma Pharmaceutical (GPA) privileges.
Any license number between 1132 and 1273 was originally issued as a Diagnostic Pharmaceutical Agents (DPA) license and must have a -2 suffix for Therapeutic Pharmaceutical Agent (TPA) privileges or a -3 for Glaucoma Pharmaceutical (GPA) privileges.
Numbers between 1274 and 1542 were originally issued as a Therapeutic license and must have a -3 for Glaucoma Pharmaceutical privileges. New licenses issued since 1999, beginning with 1543, were issued with glaucoma treatment privileges. There is only one very rare exception: If a licensee has received his license in Kansas by reciprocity, and he was licensed at only the Diagnostic Pharmaceutical Agent (DPA) level in his original home state, he may have a license number higher than 1274 with a -1 suffix.